Showing results (651-660 of 865) with videos related to
Sort By:
Pageof 87
The Journal of Experimental Medicine|August 1, 1987
Complete amino acid sequences of variable regions of two human IgM rheumatoid factors, BOR and KAS of the Wa idiotypic family, reveal restricted use of heavy and light chain variable and joining region gene segmentsM M Newkirk, R A Mageed, R Jefferis, et al.Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 5, 2007
Clinical experience with a chronic pain management programme in Hong Kong Chinese patientsAlice K Y Man, M C Chu, P P Chen, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
Isolation, characterization and sequence analysis of five IgG monoclonal anti-beta 2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage displayR U Chukwuocha, E T Hsiao, P Shaw, et al.American Journal of Ophthalmology|August 1, 1995
A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygiumP P Chen, R G Ariyasu, V Kaza, et al.The Journal of Clinical Investigation|November 1, 1989
A natural autoantibody is encoded by germline heavy and lambda light chain variable region genes without somatic mutationK A Siminovitch, V Misener, P C Kwong, et al.Journal of Cellular Biochemistry|June 1, 1993
Biosynthesis and function of membrane bound and secreted forms of recombinant CD11b/CD18 (Mac-1)P W Berman, G R Nakamura, L Riddle, et al.Biotechnology and Bioengineering|June 18, 2005
In silico design and adaptive evolution of Escherichia coli for production of lactic acidStephen S Fong, Anthony P Burgard, Christopher D Herring, et al.Genetics and Molecular Research : GMR|March 20, 2012
Lack of association between Gly82Ser, 1704G/T and 2184A/G of RAGE gene polymorphisms and retinopathy susceptibility in Malaysian diabetic patientsZ X Ng, U R Kuppusamy, R Poh, et al.Journal of Natural Products|March 28, 2006
Antimalarial compounds from Grewia bilamellataCuiying Ma, Hong Jie Zhang, Ghee Teng Tan, et al.Ophthalmology Science|May 1, 2023
Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in GlaucomaYang Sun, David Wirta, Wendy Murahashi, et al.Pageof 87